Insulet Corp: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 22, 2018 and accepted by EDGAR at Feb 21, 2018, 17:47 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $186.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-10-01 to 2017-12-31 | $79.5m | us-gaap:GrossProfit |
| Gross profit | 12 months2017-01-01 to 2017-12-31 | $277.2m | us-gaap:GrossProfit |
| Research and development | 12 months2017-01-01 to 2017-12-31 | $74.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-10-01 to 2017-12-31 | −$768.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2017-01-01 to 2017-12-31 | −$7.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2017-01-01 to 2017-12-31 | $21.2m | us-gaap:InterestExpense |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $257.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-10-01 to 2017-12-31 | −$6.9m | us-gaap:NetIncomeLoss |
| Net income | 12 months2017-01-01 to 2017-12-31 | −$26.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-10-01 to 2017-12-31 | −$0.12 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | $41.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $77.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-12-31 | $272.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $537.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $816.7m | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $86.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $658.2m | us-gaap:Liabilities |
| Long-term debt | At period end2017-12-31 | $566.2m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2017-12-31 | $158.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-18-000004. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.